TD Asset Management
VERA icon

TD Asset Management’s Vera Therapeutics VERA Stock Holding History

TD Asset Management’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.5M Sell
128,070
-65,924
-34% -$2.46M ﹤0.01% 790
2026
Q1 		$7.8M Sell
193,994
-131,570
-40% -$5.67M 0.01% 703
2025
Q4 		$16.5M Buy
325,564
+115,090
+55% +$4.09M 0.01% 545
2025
Q3 		$6.12M Buy
210,474
+10,200
+5% +$236K 0.01% 749
2025
Q2 		$4.72M Sell
200,274
-51,890
-21% -$1.17M ﹤0.01% 772
2025
Q1 		$6.06M Buy
252,164
+21,606
+9% +$694K 0.01% 750
2024
Q4 		$9.75M Buy
230,558
+37,664
+20% +$1.67M 0.01% 651
2024
Q3 		$8.38M Buy
192,894
+38,556
+25% +$1.46M 0.01% 679
2024
Q2 		$5.58M Buy
154,338
+24,000
+18% +$952K 0.01% 740
2024
Q1 		$5.62M Buy
+130,338
New +$4.64M 0.01% 748

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return

TD Asset Management's VERA Position: Q2 2026 in Review

TD Asset Management reduced its Vera Therapeutics (VERA) stake by 34% in Q2 2026, selling an estimated $2.46M and leaving 128,070 shares worth $5.5M. The position accounts for ﹤0.01% of the portfolio, ranked #790.

TD Asset Management first reported a position in VERA in Q1 2024 and has held it in 10 quarters since. The position peaked at $16.5M in Q4 2025. 129 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • TD Asset Management held 128,070 shares of Vera Therapeutics worth $5.5M as of Q2 2026.
  • TD Asset Management sold 65,924 Vera Therapeutics shares in Q2 2026, an estimated $2.46M.
  • Vera Therapeutics made up ﹤0.01% of TD Asset Management's portfolio in Q2 2026, its #790 holding.
  • TD Asset Management first reported a position in Vera Therapeutics in Q1 2024 and has held it in 10 quarters since.
  • TD Asset Management's Vera Therapeutics position peaked at $16.5M in Q4 2025.
  • 129 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on TD Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.